Skip to main content

Recent News

  • Jun 02, 2023
    A nationwide population-based study, by Beydon et al. (OP0044), has performed a more recent (2010-2020) analysis of cancer incidence in people living with RA within the French national claim database, compared to general population, measured in the French Network of Population-Based Cancer Registries.
    Read Article

AI in RA: the story grows along the patient pathway

Jun 02, 2023

The use of artificial intelligence to analyse large data sets using its subset component machine learning has taken centre stage recently in the management of rheumatic conditions including rheumatoid arthritis. The use of AI is now starting to cross the various stages in patient care from detection, diagnosis, treatment and the prediction of long-term outcome.

Read Article

Unmasking Lupus Pregnancy: Adherence and Drug Monitoring Dilemmas

Risk of poor pregnancy outcomes in lupus patients continues to remain high, especially in the setting of high disease activity. Preliminary data from a lupus pregnancy LEGACY cohort presented at EULAR 2023 raise concern.

Read Article
Using app for self-management in clinical care. There is a need to have continued engagement both patients and clinicians, constantly evolve the product, adapt to the changing needs of patients eg.pre and post pandemic, #WIIFM? @AurelieRheumo @ProfYelizPrior #EULAR2023 @RheumNow
Metabolic Burden in the Early Stages of PsA Dr. Aurelie Najm ( @AurelieRheumo )discusses abstract OP0066 presented at EULAR 2023 in Milan, Italy.
Jun 02, 2023
The #EULAR2023 wall is growing..@RheumNow
Very interesting. Overweight fibromyalgia pts had some sustained benefit of their fibro on a very low calorie ketogenic diet (8 weeks ketogenic, 12 weeks carb reintroduce) Pain improvements matched weight loss. Many questions, I want to see more! POS1339 #EULAR2023 @RheumNow
Jun 02, 2023
Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn.
Jun 02, 2023
✅Benefit of adding #HydroxyChloroquine #HCQ in refractory obstetric #APS #EULAR2023 poster
Clinically suspect arthralgia-what is needed are predictors that enrich WHO will develop RA. Otherwise in 85% of Pts your (sham) Rx will work. If we need to reset the immune response- early makes sense but many will NOT have #RA over the next few yrs. ⁦@RheumNow⁩ #EULAR2023
#EULAR2023 #OP0290 Heterogeneity in #SLE is not only disease features but think of ANCESTRY. Data from BILAG-BR registry showed worse outcomes in people of Black and South Asian treated with either Rituximab or Belimumab (adjusted for deprivation index) @RheumNow
Predictors of first hospitalizations due to disease activity and infections in #lupus 1341 pts from multicenter latin american cohort. 33% with atleast one hospitalization, and 3/4th due to disease activity. @rheumnow #EULAR2023 abt#POS0169
Evaluation of diagnostic performance of ACR 1997, SLICC 2012 and EULAR /ACR diagnostic crieteria in childhood onset #SLE - SLICC highest sensitivity early in the disease, ACR1997 has the highest specificity both at diagnosis ans over time. @RheumNow #EULAR2023 abst#POS0136
Factors associated with higher prevalence of post COVID-19 condition include female sex, age, asthma, diabetes, hypertension, number of symptoms in the acute phase and possible mechanisms causing the syndrome, Mayssam Nehme, COVID-19, #EULAR2023
#EULAR2023 #OP0289 We need to improve health equity in the care of people with arthritis. An online survey showed that Black, Indigenous and People of Colour (BIPOC) Women in Canada faced a)unique & disproportionate barriers and b) complex experiences of discrimination @RheumNow
Predictors of myocarditis in anti-synthetase syndome - 43 pta 30% with myocarditis. More frequently males with high troponin levels. Only fever was more frequently observed in myocarditis pts. Pos1224 @rheumnow #EULAR2023
#Clinically suspect #arthralgia debate ⁦BE CAREFUL how you apply the criteria as sensitivity / specificity will vary if low pretest likelihood. ⁦@eular_org⁩ ⁦@RheumNow⁩
Reflections on COVID-19 and autoimmunity: post-vaccination autoimmunity is not specific to COVID-19, autoimmunity is not autoimmune disease, the large numbers may result in the perception of increased occurrence of autoimmunity, Schulze-Koops H, COVID-19, #EULAR2023 @RheumNow
« Science is a work of Art » Yes it is. If you are not convinced, have a look at this Twitter account that merges Van Gogh and #histology 👀 @RheumNow #EULAR23 👇🏼👇🏼👇🏼👇🏼
RheumNow’s expanded coverage of the #EULAR2023 Annual meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its Faculty.
Jun 02, 2023
#ClinicalPearls #rheumatoid #arthritis is changing. Less extra articulation and less mortality except ILD. Legacy pts exposed to ASA high dose, NSAIDs and injectable gold. We still see it rarely. @RheumNow #EULAR2023 @eular_org